Funding sources None.
1468-3083/asset/JDV_left.gif?v=1&s=1f5077e9ad670d0243350067014f92a67f0587c2)
SHORT REPORT
You have free access to this content
Confluent and reticulated papillomatosis: clinical and histopathological study of 10 cases from Lebanon
Article first published online: 3 NOV 2011
DOI: 10.1111/j.1468-3083.2011.04328.x
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology
Issue
Journal of the European Academy of Dermatology and Venereology
Volume 27, Issue 1, pages e119–e123, January 2013
Additional Information
How to Cite
Tamraz, H., Raffoul, M., Kurban, M., Kibbi, A.-G. and Abbas, O. (2013), Confluent and reticulated papillomatosis: clinical and histopathological study of 10 cases from Lebanon. Journal of the European Academy of Dermatology and Venereology, 27: e119–e123. doi: 10.1111/j.1468-3083.2011.04328.x
Conflict of interest None declared.
Publication History
- Issue published online: 18 DEC 2012
- Article first published online: 3 NOV 2011
- Received: 4 June 2011; Accepted: 12 October 2011
References
- 1, . Papillomatose pigmente′e innomine′e. Bull Soc Fr Dermatol Syphiligr 1927; 34: 719.
- 2. Confluent and reticulated papillomatosis : a review of the literature. Am J Clin Dermatol 2006; 7: 305–313.
- 3, , . Confluent and reticulated papillomatosis (Gougerot–Carteaud). An abnormal host reaction to Malassezzia furfur. Acta Derm Venereol 1973; 53: 381–384.
- 4, , . Confluent and reticulated papillomatosis associated with tinea versicolor in three siblings. Pediatr Dermatol 2005; 22: 331–333.
- 5, , . Familial confluent and reticulated papillomatosis. Arch Dermatol 2002; 138: 276–277.
- 6, , . Confluent and reticulate papillomatosis (Gougerot–Carteaud syndrome): a minocycline-responsive dermatosis without evidence for yeast in pathogenesis. A study of 39 patients and a proposal of diagnostic criteria. Br J Dermatol 2006; 154: 287–293.
- 7, . Confluent and reticulated papillomatosis responsive to selenium sulfide. Int J Dermatol 1986; 25: 194–199.
- 8
- 9, . Confluent and reticulated papillomatosis responsive to minocycline. Dermatology 1997; 194: 59–61.
- 10, , . Confluent and reticulated papillomatosis: clinical, light, and electron microscopic studies. Int J Dermatol 1992; 31: 480–483.
- 11, , et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003; 139: 459–464.
- 12, . Antiinflammatory capabilities of macrolides. Pharmacol Res 2001; 44: 451–454.
- 13, . Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 2006; 54: 258–265.
- 14, , . Clinical applications of non-antimicrobial tetracyclines in dermatology. Pharmacol Res 2011; 63: 130–145.
- 15, , et al. Confluent and reticulated papillomatosis: response to minocycline. J Am Acad Dermatol 1996; 34: 253–256.
- 16, , , . Confluent and reticulated papillomatosis: favourable response to low-dose isotretinoin. J Eur Acad Dermatol Venereol 2009; 23: 1342–1343.
- 17, , et al. Confluent and reticulated papillomatosis: response to high-dose oral isotretinoin therapy and reassessment of epidemiologic data. J Am Acad Dermatol 1994; 31: 327–331.
- 18, . Confluent and reticulated papillomatosis: response to tazarotene. J Am Acad Dermatol 2003; 48(Suppl): S80–S81.
- 19, . Response of confluent and reticulate papillomatosis of Gougerot and Carteaud to topical tretinoin. Cutis 2000; 66: 291–293.
- 20, , et al. Calcipotriol treatment of confluent and reticulated papillomatosis (Gougerot–Carteaud syndrome). J Eur Acad Dermatol Venereol 2000; 14: 131–133.